Healthcare · Pharmaceuticals & Biotechnology
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 1 Sep 2026 | PRIYA KABRA | Bulk | Sell | 51,000 | 40.7100 | BSE |
| 1 Sep 2026 | PRIYA KABRA | Bulk | Buy | 51,000 | 40.9100 | BSE |
| 31 Aug 2026 | AMOL LAXMIKANT MUJUMDAR | Bulk | Buy | 60,000 | 41.0000 | BSE |
| 31 Aug 2026 | VEER SINGH THAKUR | Bulk | Sell | 60,000 | 41.0000 | BSE |
| 28 Aug 2026 | SWAPAN KHANDELWAL | Bulk | Buy | 78,000 | 40.9700 | BSE |
| 25 Aug 2026 | VEER SINGH THAKUR | Bulk | Sell | 3,000 | 40.0000 | BSE |
| 25 Aug 2026 | CUMULATIVE CAPITAL PRIVATE LIMITED | Bulk | Sell | 51,000 | 40.1500 | BSE |
| 25 Aug 2026 | VEER SINGH THAKUR | Bulk | Buy | 51,000 | 40.1500 | BSE |
| 25 Aug 2026 | AJIT SINGH | Bulk | Buy | 60,000 | 40.0400 | BSE |
| 25 Aug 2026 | KAILASH KABRA | Bulk | Buy | 96,000 | 40.1400 | BSE |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 2 Sep 2026 | Insider Trading / SAST | Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 2 Sep 2026 | Insider Trading / SAST | Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 1 Sep 2026 | Insider Trading / SAST | Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
